Takeda Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 12,000 | 0.000757% |
Public Companies | 275,000 | 0.0173% |
Individual Insiders | 968,685 | 0.0611% |
Company Controlled Foundation | 17,912,000 | 1.13% |
Institutions | 751,745,310 | 47.4% |
General Public | 814,267,599 | 51.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
117,311,056 | US$3.1b | 0.19% | 0.05% | |||
72,675,000 | US$1.9b | -0.47% | 0.65% | |||
60,709,654 | US$1.6b | 3.34% | 0.02% | |||
50,891,334 | US$1.4b | 0% | 0.94% | |||
42,568,377 | US$1.1b | -1.18% | 0.05% | |||
36,509,500 | US$969.8m | 0% | 0.35% | |||
33,150,000 | US$880.6m | 50.5% | 2.62% | |||
31,941,500 | US$848.5m | -1.45% | 0.59% | |||
29,501,697 | US$783.6m | 26.1% | 0.33% | |||
24,752,000 | US$657.5m | 0% | 0.73% | |||
23,923,467 | US$635.5m | 0% | 0.05% | |||
18,683,200 | US$496.3m | -7.77% | 0.27% | |||
17,912,000 | US$475.8m | 0% | no data | |||
14,363,243 | US$381.5m | 0% | 0.03% | |||
9,148,868 | US$243.0m | 0.86% | 0.04% | |||
8,074,200 | US$214.5m | 0% | 0.44% | |||
7,380,592 | US$196.1m | 1.58% | 0.02% | |||
6,846,750 | US$181.9m | -0.03% | 0.05% | |||
6,625,900 | US$176.0m | 0% | 0.5% | |||
6,428,296 | US$170.8m | -5.72% | 0.72% | |||
5,822,502 | US$154.7m | 0.71% | 0.02% | |||
5,413,524 | US$143.8m | 0.57% | 0.01% | |||
5,334,600 | US$141.7m | -0.93% | 0.17% | |||
4,623,740 | US$122.8m | -0.45% | 0.02% | |||
4,404,298 | US$117.0m | 101% | 0.01% |